ARCHIVES

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Shift Towards More Treatable AIDS Lymphomas Identified

July 25, 2003

In Brief: Sartorelli AACI President, McInTyre President Elect; Moertel to Receive ACCC Clinical Award

July 10, 1987

Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial.

June 15, 2007

Business & Regulatory Report March edition (8 pages) included.

March 19, 2004

Board Defers core Guideline changes, Asks Subcommittee For Alternate Plans

November 18, 1977

Hormonal Therapy Improves Prostate Cancer Survival

August 27, 2004